Belle Health vs Found

One names the pharmacy. The other opens the brand-name road.

Belle Health prints the names of more than one compounding pharmacy it works with. Found describes its pharmacies only as 503A-licensed, which is a class rather than an identity.

Found sells something Belle Health does not: brand-name GLP-1s, on a separate track from its compounded program, each at its own listed price. Belle publishes compounded products only.

Those are the two poles of this comparison. Knowing who prepared your compounded medication, or having an FDA-approved product available behind the same intake. Neither provider offers both.

How long each one wants you for

Found's lowest advertised rate requires prepaying a full year. Month-to-month billing lands substantially higher, and the step is large rather than a rounding difference.

Belle Health asks for less. Its tirzepatide rate is a three-month bundle, and a shorter term costs more each month. On semaglutide there is no bundle requirement at all.

For a first-time patient, three months and twelve months are not the same kind of decision. Found does publish a specific refund policy for its membership fee, which is more than most of this field commits to. Read that policy against the prepaid term, because the two interact.

Which compound you want changes the answer

Across this category tirzepatide usually costs more than semaglutide, and Belle Health follows that pattern with a bundle attached to the better rate.

Found does not. One flat program price covers either compound, so a patient who wants tirzepatide from the start avoids the premium, and one who switches later does not walk into an increase.

That skews a careless comparison. Found looks strongest on tirzepatide and less distinctive on semaglutide, where Belle's rate carries no bundle at all. Check which drug a figure belongs to before treating it as a verdict on either platform.

The Belle Health warning letter, stated plainly

Belle Health received FDA warning letter No. 721795, issued in February 2026. It concerned how Belle's website displayed Belle branding alongside the compounded semaglutide and tirzepatide it sells. The agency's position was that the presentation implied Belle itself manufactured those drugs.

That is a marketing and presentation matter. It is not a finding about the contents of a vial, and it is not reported as one. Found carries no warning letter.

The useful takeaway is narrow: Belle has been formally corrected once on how it describes its relationship to the drugs it sells, which is a reason to read its marketing claims literally. Some readers rule out any company with a regulatory action, and that call is better made with the letter in front of you.

What each publishes about itself

Found displays a LegitScript seal and states BBB accreditation. Both are published claims. A seal appearing on a page establishes that a seal is published, not who holds the underlying certificate, and it is not converted into one here.

Belle Health publishes no accreditation seal, and its transparency runs in a different direction: it names pharmacies, which several larger platforms will not. It also includes a weekly registered dietitian session in the membership rather than selling nutrition support on the side. That is worth something only if you will use it.

Found's own pricing pages state different starting points for brand-name medication, and the gap is wide. That discrepancy is not resolved here. Get a brand-name figure in writing for your own situation before relying on it.

So which one

It depends on which of these matters more to you. If an FDA-approved brand-name option behind the same account is the point, or you want tirzepatide without a premium, Found is the one that offers it.

If you will not buy a compounded medication without knowing which pharmacy made it, Belle Health answers that. It also asks for far less commitment than a prepaid year.